#COVID19: Cameroon Govt Approves Local Drugs By Catholic Prelate And An Imam
This makes it the fifth locally produced medication to enhance Covid-19 treatment in Cameroon.
Cameroon’s Ministry of Public Health has approved four drugs produced using local herbs for the treatment of the COVID-19.
The approval of the drugs for use comes after the favourable opinion of the country’s National Drugs Commission.
The approved drugs are Adsak COVID and Elixir COVID by the Catholic Archbishop of the Douala metropolitan archdiocese, Monsignor Samuel Kleda, Soudicov Plus by Imam Modibo Soudi-Rey, and Palubek by Christelle Bekono.
The drugs have a validity of three years and are considered as facilitators to enhance the effectiveness of COVID-19 treatment.
According to Dr Salihou Sadou, Director of Pharmacy, Drugs and Laboratories in the Ministry of Public Health, the four locally produced drugs do not alone treat COVID-19 but can be associated with existing protocols to enhance effective treatment of the virus.
The four newly-authorized COVID-19 treatment drugs bring to five, the number of Cameroonian produced drugs validated by the Cameroon government. The first one to be approved for use in the treatment of COVID-19 was Corocur by Dr Euloge Yiagnigni Mfopou.
Latest statistics published by the Ministry of Public Health indicates that as of July 15, 2021, Cameroon has recorded 81,467 COVID-19 positive cases with 79,825 patients successfully cured and 1,338 deaths.
So far, 220,776 Cameroonians have received the first dose of vaccination against the virus while 27,975 have received the second dose.
Support Our Journalism
There are millions of ordinary people affected by conflict in Africa whose stories are missing in the mainstream media. HumAngle is determined to tell those challenging and under-reported stories, hoping that the people impacted by these conflicts will find the safety and security they deserve.
To ensure that we continue to provide public service coverage, we have a small favour to ask you. We want you to be part of our journalistic endeavour by contributing a token to us.
Your donation will further promote a robust, free, and independent media.Donate Here